825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Reports Second Quarter 2026 Financial Results and Provides Business Update
Director Retirement - Heath Lukatch Steps Down from Vaxcyte Board
Director Retirement - Jacks Lee Steps Down from Vaxcyte Board
Vaxcyte, Inc. Annual Meeting Results - Directors Elected
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Vaxcyte Enters $500 Million Sales Agreement with Leerink Partners
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload
Correspondence